?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
November 20, 2019
signalgroup
Biosimilars Forum Statement Regarding Nomination of Dr. Stephen Hahn as Next Commissioner of the Food and Drug Administration (FDA)
News
November 13, 2019
signalgroup
The Biosimilars Forum Reacts to CMS Report on Increased Medicare Premiums for Seniors
News
November 11, 2019
signalgroup
ICYMI: Trump Administration’s Joe Grogan Recognizes Need for Biosimilar Incentives to Help Lower Healthcare Costs
News
October 18, 2019
signalgroup
The Biosimilars Forum Applauds Launch of New FDA Performance Dashboard
News
October 9, 2019
signalgroup
The Biosimilars Forum Applauds Congressmen Paul Tonko (D-NY) and Bob Gibbs (R-OH) for Introducing Legislation Mandating a CMS Star Ratings Program for Biosimilars
News
October 3, 2019
signalgroup
President Trump Can Easily Reduce Health Care Costs for U.S. Seniors and Taxpayers by Increasing Biosimilar Use
News
October 3, 2019
signalgroup
New Analysis Confirms All 50 States Stand to Benefit from Increased Use of Biosimilars
News
October 1, 2019
signalgroup
The Biosimilars Forum Applauds Congressmen Scott Peters, Pete King and Anthony Brindisi For Introducing $0 Copay Biosimilars Legislation for Medicare Part B
News
September 20, 2019
signalgroup
The Biosimilars Forum Applauds Bipartisan Introduction of the BIOSIM Act
News
September 19, 2019
signalgroup
House Energy & Commerce Committee Hearing Highlights How Biosimilars Can Save Patients Money
Prev page
10
11
12
13
14
Next page